New SPECT Study Unveils Significant Brain Activity Differences in Depression
Researchers in a groundbreaking neuroimaging study have discovered that individuals with depression exhibit significantly higher levels of blood flow in...
MDD
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
